Sartorius AG · XETR:SRT

Sartorius — ESG Presentation (October 2018)

32 slides from Sartorius's sustainability presentation, October 2018

  1. Slide 1: Corporate Sustainability Presentation

    Corporate Sustainability Presentation

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains statements concerning the Sartorius Group’s future performance. These statements are based on assumptions and estimates. Although we are convinced that these forward- looking statements are realistic, we cannot guarantee that they will actually materialize. This

  3. Slide 3: Agenda

    Agenda 01 Sartorius Overview, Values and Governance 02 Solutions for Health and Science 03 Resource-efficient Manufacturing 04 Responsible and Attractive Employer

  4. Slide 4: A Company With Strong Roots

    Sartorius Overview, Values and Governance A Company With Strong Roots  Leading bioprocess and lab equipment provider  €1.4bn sales revenue; 25% earnings1 margin  Stable ownership structure  Listed in the German MDAX & TecDAX, MC €10.3bn2  Founded 1870 by Florenz Sartorius  Double university sp

  5. Slide 5: We have Evolved into a Specialist for Pharma|Biotech

    Sartorius Overview, Values and Governance We have Evolved into a Specialist for Pharma|Biotech Until 1990: Today: Focus on Technology Solution Provider for Biopharma Labs and Processes Lab Products for Process Biopharma Bio/Pharma Development Production Weighing Filtration  Broad range of customer

  6. Slide 6: 150 Years of Corporate History Built on Strong Values

    Sartorius Overview, Values and Governance 150 Years of Corporate History Built on Strong Values Employees Continuing professional growth and long-term employment; adopt creative, new approaches to drive innovation Customers | Partners | Suppliers Trusting and long-term profitable business relations

  7. Slide 7: Dimensions at Sartorius

    Sartorius Overview, Values and Governance Dimensions at Sartorius  Focus on profitable growth  Motivated, well- trained employees Economic  Well-established set  Diversity considered success of guidelines, principles as an opportunity Active use of Compliance and control systems global employee

  8. Slide 8: Sartorius' Dual Board Structure

    Sartorius Overview, Values and Governance Sartorius‘ Dual Board Structure Executive Board Supervisory Board 3 members 12 members: 6 shareholder representatives , thereof 5 independent, 6 employee representatives Exec. Task Audit Nomination Mediation Committee Committee Committee Committee Dr. Joachi

  9. Slide 9: Risk and Opportunities Management and Compliance

    Sartorius Overview, Values and Governance Risk and Opportunities Management and Compliance Supervisory Board Executive Board Risk Reporting ICS | Compliance Internal Auditing Risk and Opportunities Identification and Management by operating functions Other Guidelines Global Risk Mgmt. Guidelines Loc

  10. Slide 10: Strong Framework of Group Policies

    Sartorius Overview, Values and Governance Strong Framework of Group Policies Key Group Policies  Code of Conduct Key Topics  Anti-corruption Code  Workplace environment  Supplier Code of Conduct  Labour rights  ICS Manual  Compliance with laws and statutes  Conformity with the German  Fair

  11. Slide 11: Agenda

    Agenda 01 Sartorius Overview, Values and Governance 02 Solutions for Health and Science 03 Resource-efficient Manufacturing 04 Responsible and Attractive Employer

  12. Slide 12: Biopharmaceutical Manufacturing is Complex and Expensive

    Solutions for Health and Science Biopharmaceutical Manufacturing is Complex and Expensive Small Molecules Since 19th c. Advantages of biopharmaceuticals  First-time or improved treatment of serious illnesses, such as cancer, Chemical drugs multiple sclerosis, rheumatism 21 atoms  Targets only spec

  13. Slide 13: Sartorius Laboratory and Bioprocess Technologies Enable Medical Progress and Affordable Biopharmaceuticals

    Solutions for Health and Science Sartorius Laboratory and Bioprocess Technologies Enable Medical Progress and Affordable Biopharmaceuticals Research & Development Production Quality Control Unique bioanalytical Sample prep. technologies instruments and consumables Innovative SU products for and anal

  14. Slide 14: Strategic focus on biopharma market

    Solutions for Health and Science Strategic focus on biopharma market ~72% Bioprocess Solutions Division of Group Sales Cell line and Production Molecule Development Process Development Upstream & Downstream Quality and Testing ~28% Lab Products & Services Division of Group Sales Based on FY 2017 fig

  15. Slide 15: We offer The Widest Portfolio Across the Biopharma Process Chain

    Solutions for Health and Science We offer The Widest Portfolio Across the Biopharma Process Chain Process Upstream Processing Downstream Processing Development Media Media Seed Seed Production Cell Removal Cell RemovalCapture | Polishing Virus Viral Preparation Fermentation Preparation Fermentation

  16. Slide 16: Single-Use Bioproduction Technologies Have Multiple Benefits

    Solutions for Health and Science Single-Use Bioproduction Technologies Have Multiple Benefits Economic and operational benefits Environmental benefits  Significant cost savings  > 80% reduction of water consumption  Flexibility & speed  ~ 30% energy savings  Reduced risk of cross-contamination

  17. Slide 17: Innovation Focuses Also on Ecological Advantages

    Solutions for Health and Science Innovation Focuses Also on Ecological Advantages Sartopore Platinum  Fewer cartridges and accessories  Less filtration time  Higher yields  Up to 95% less ultrapure water needed Centrisart Centrifuge  Low energy consumption  Use of recyclable materials  CFC-fr

  18. Slide 18: We Help to Make R&D Work More Efficient ...

    Solutions for Health and Science We Help to Make R&D Work More Efficient ... iQue cell screening platform  delivers results more than 10x faster than any other technology Virus Counter  determines total virus particle concentration just in minutes, not days ambr multi-parallel bioreactors  signif

  19. Slide 19: ... and Ensure User-friendly Working Conditions

    Solutions for Health and Science ... and Ensure User-friendly Working Conditions Pipette - Tacta  Ergonomic design ensures an optimal working posture  Effortless, electronic tip ejection  Reduces the risk of work related upper limb disorder (WRULD) Lab filter - Claristep  Syringeless and fast fi

  20. Slide 20: Agenda

    Agenda 01 Sartorius Overview, Values and Governance 02 Solutions for Health and Science 03 Resource-efficient Manufacturing 04 Responsible and Attractive Employer

  21. Slide 21: Sartorius Runs a Modern and Efficient Production Network

    Resource-efficient Manufacturing Sartorius Runs a Modern and Efficient Production Network Rotterdam Vilvoorde Kajaani Helsinki Royston St. Petersburg Glasgow Dublin Stonehouse Moscow Epsom Goettingen Poznan Laupheim Tagelswangen Guxhagen Aubagne Budapest Vienna Lourdes Florence Mississauga Madrid Bo

  22. Slide 22: World's 1st Platinum-Certified Facility to Supply the Pharma Industry

    Resource-efficient Manufacturing World’s 1st Platinum-Certified Facility to Supply the Pharma Industry - 85% water consumption compared with conventional facilities LEED Platinum certified facility in Yauco | Puerto Rico  Opened 2012, main site to serve the North American market with filters and ba

  23. Slide 23: Awarded for EHS Practices by the Confederation of Indian Industry

    Resource-efficient Manufacturing Awarded for EHS Practices by the Confederation of Indian Industry 12mn liters per year of rainwater Facility in Bangalore | India, opened in 2009 harvesting & re-charging  Production site mainly for stainless steel bioreactors and a broad range of accessories  Meet

  24. Slide 24: New Headquarters Substantially Exceeds Regulatory Requirements

    Resource-efficient Manufacturing New Headquarters Substantially Exceeds Regulatory Requirements - 50% energy consumption compared with ENEV1 Sartorius Campus in Goettingen | Germany  Consolidation and expansion of manufacturing and office space in Goettingen  Certification according to DGNB2 - gol

  25. Slide 25: Sartorius Grows with Underproportionate Use of Natural Resources

    Resource-efficient Manufacturing Sartorius Grows with Underproportionate Use of Natural Resources  State-of-the-art technology to reduce emissions, e.g. combined heat & power plants  Continued improvements expected to be driven by high investments in advanced infrastructure and ongoing enhancement

  26. Slide 26: Agenda

    Agenda 01 Sartorius Overview, Values and Governance 02 Solutions for Health and Science 03 Resource-efficient Manufacturing 04 Responsible and Attractive Employer

  27. Slide 27: Motivated and Well-trained Employees Are Key to Success

    Responsible and Attractive Employer Motivated and Well-trained Employees Are Key to Success  Comprehensive training and development program in place  Structured expert and management career paths  Collective bargaining and freedom of association  Group-wide employee surveys to identify potential

  28. Slide 28: Diversity Represents an Opportunity

    Responsible and Attractive Employer Diversity Represents an Opportunity  Achieve a mix of cultures, genders and age groups  People from close to 70 nations work for Sartorius; > 60% outside Germany  More than 50 subsidiaries worldwide are managed by local managers  Share of women in managerial p

  29. Slide 29: How Sartorius Defines Work Safety ...

    Responsible and Attractive Employer How Sartorius Defines Work Safety ...  High safety standards based on ILO and national regulations  Regular training on health and safety at work  Corporate sports groups and “health awareness days”  Sponsored health protection programs, such as flu vaccinatio

  30. Slide 30: Sartorius is a Responsible Neighbor with Strong Social Commitment

    Responsible and Attractive Employer Sartorius is a Responsible Neighbor with Strong Social Commitment Close relationship and open dialogue Christmas Initiative: Donations instead of gifts with communities Scholarship programs at main Sartorius locations Sponsoring for student lab Financial support f

  31. Slide 31: Contacts

    Contacts Petra Kirchhoff Ben Orzelek Head of Head of Corporate Communications & IR Investor Relations Phone: +49.551.308.1686 Phone: +49.551.308.1668 E-mail: E-mail: petra.kirchhoff@sartorius.com ben.orzelek@sartorius.com Sartorius Corporate Administration GmbH Otto-Brenner-Straße 20 37079 Goettinge

  32. Slide 32: Strong Financial Track Record

    Strong Financial Track Record Sales CAGR ~ +13% EBITDA1) margin +5.4pp +~12-15% 00 +9,3% 30 +18.2% 29 00 +16.0% 28 +12.6% +8.8% 00 27 00 +13.6% 26 ~ 25,6 25 25.0 25.1 €733m 00 24 23.6 23 00 ~€650m 22 00 21 21.0 20 20.5 20.1 00 19.7 19 0 18 2011 2012 2013 2014 2015 2016 2017 2018e Sales revenue EBITD

Sartorius — ESG Presentation (October 2018) on 6ix